查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439314

血管閉合裝置 - 全球市場回顧、競爭格局、市場預測 (2030)

Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球血管閉合器械市場規模預計2023年將達到11.1億美元，2030年將達到15.9億美元，2024-2030年預測期間複合年增長率為6.18%。諸如心肌梗塞等心血管疾病的盛行率不斷上升、與肥胖和高血壓等心血管疾病相關的危險因子的盛行率不斷上升、人口老化的加劇以及微創手術的快速普及等因素預計將推動這一趨勢的發展。血管閉合器械市場。

血管閉合裝置市場動態

由於全球心血管疾病盛行率不斷上升，血管閉合裝置市場的需求不斷增加。根據世界衛生組織 (WHO) (2023) 提供的數據，心血管疾病 (CVD) 是全球主要死亡原因，每年估計奪走 1,790 萬人的生命。此外，同一世界衛生組織數據顯示，超過五分之四的心血管疾病相關死亡是由中風和心臟病引起的，其中三分之一的死亡發生在 70 歲以下的早期死亡中。估計。

根據歐洲心臟學會（ESC）（2023）的數據，心血管疾病（CVD）每年導致歐洲 390 萬人死亡，歐盟（EU）超過 180 萬人死亡。它約佔歐洲所有死亡人數的 45%，佔歐盟的 37%。

常見的心血管疾病包括冠狀動脈心臟病、中風、週邊性心臟病、心臟衰竭等。

此外，不健康的生活習慣，例如久坐的生活方式，導致所有年齡層的肥胖盛行率增加。根據世界衛生組織（WHO）發佈的肥胖情況說明書（2023年），超過19億18歲以上成年人超重，其中6.5億人肥胖。肥胖被認為是發生心血管疾病的主要危險因子之一。據認為，肥胖增加會增加血壓並增加心血管疾病的發生率。

因此，心血管疾病和相關危險因子的日益普及導致對用於診斷和治療目的的介入心臟手術（例如血管攝影和血管成形術）的需求增加。因此，對血管閉合裝置的需求不斷增加，因為它們有助於以省時的方式密封進入部位。

此外，微創手術的日益普及（例如新的發展）繼續推動 VCD 的使用。目前的趨勢集中在開發能夠安全有效地閉合大口徑股動脈切口的設備。隨著經導管主動脈瓣修復術和經皮血管內動脈瘤修復術變得越來越普遍，人們有很大的動力去開發和證明簡單而有效的 VCD 的實用性。

然而，與血管閉合裝置相關的併發症以及血管閉合裝置在閉合大直徑穿刺時的限制可能成為血管閉合裝置市場成長的某些限制因素。

血管閉合裝置市場區隔分析

在血管閉合裝置市場的產品領域，血管裝置的動態接近器類別預計將在血管閉合裝置市場中佔據重要的收入份額。這歸因於其優於靜態接近器的質量，與需要更長時間才能停止血流的靜態接近器相比，它可以立即閉合血管。動態逼近器進一步分為基於縫合的、基於夾子的和壓縮輔助設備。

此外，由於基於生物材料的設備日益普及，靜態近似器類別預計在預測期內將呈現出血管閉合設備的更快成長。

預計北美將主導整個血管閉合裝置市場。

在所有地區中，預計北美將佔據血管閉合裝置市場的主要市場份額。由於心血管疾病及相關危險因子的高盛行率、老年人口的增加、疾病管理意識高以及購買此類設備的能力等，預計北美將佔據主導市場份額。

本報告提供了全球血管閉合裝置市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第一章血管閉合裝置市場報告簡介

第二章血管閉合裝置市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估
  • 財務基準

第三章 法規與專利分析

  • 美國
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
  • 日本

第四章血管閉合器械市場關鍵因素分析

  • 血管閉合裝置市場驅動因素
    • 心血管疾病增加
    • 與 CVD 相關的危險因子盛行率增加
    • 微創手術越來越受歡迎
    • 產品創新活動快速增加
  • 血管閉合器械市場的限制因素與挑戰
    • 與血管閉合裝置相關的併發症
    • 血管閉合裝置在閉合大直徑穿孔時的局限性
  • 血管閉合裝置市場機遇
    • 生物可吸收血管閉合器的研製

第五章血管閉合裝置市場的波特五力分析

第六章 COVID-19對血管閉合器械市場的影響分析

第七章血管閉合器市場佈局

  • 按產品類型
    • 動態逼近器
    • 靜態逼近器
    • 其他
  • 按訪問類型
    • 大腿
    • 半徑
  • 按最終用戶
    • 醫院
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第八章血管閉合裝置市場：全球公司份額分析 - 3至5家主要公司

第九章血管閉合裝置市場公司與產品概況

  • Abbott
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Medtronic
  • Cardinal Health
  • Cardival Medical, Inc
  • Merit Medical systems
  • Morris Innovative
  • TZ Medical
  • Vasorum Ltd
  • Tricol Biomedical
  • Vivasure Medical Ltd.
  • Transluminal Technologies
  • W. L. Gore & Associates, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Gem srl

第10章 項目方法

  • 二次資料
  • 一次資料
  • 數據三角測量
  • 主要專家意見

第11章 KOL觀點

第12章 DelveInsight服務內容

第13章 免責聲明

第 14 章關於 DelveInsight

Product Code: DIMDCL0106

Vascular Closure Devices Market By Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based And Bioabsorbable Plugs], and Others), By Access (Femoral And Radial), and By End User (Hospitals & Clinics, Ambulatory Surgical Centers, ad Others), By Geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of cardiovascular diseases such as heart strokes and increasing prevalence of obesity.

Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030. Factors such as the growing prevalence of cardiovascular disorders such as heart strokes, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.

Vascular Closure Devices Market Dynamics:

The vascular closure devices market is witnessing an increase in demand due to the rising prevalence of cardiovascular diseases the globe. As per the data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) are the leading cause of death across the globe, accounting for an estimated 17.9 million loss of lives each year. Furthermore, the same data by the WHO presented that over four out of five deaths related to cardiovascular diseases list strokes and heart attacks as the main cause, and one-third of these deaths are estimate to occur prematurely in people below 70 years of age.

According to the data provided by the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the European Union.

Some of the common cardiovascular diseases include coronary heart disease, strokes, peripheral heart disease, and heart failure among others.

Furthermore, the unhealthy lifestyle such as sedentary lifestyle has led to the increased prevalence of obesity in the world across all age groups. According to the factsheet provided by the World Health Organization on Obesity (2023), over 1.9 billion adults in the age group of 18 and above were overweight, out of which 650 million people were obese. Obesity is considered as one of the major risk factors for the development of cardiovascular diseases. It has been observed that the increase body mass index results in the increase in blood pressures and rates of cardiovascular diseases.

Therefore, the increase in the prevalence of cardiovascular diseases and the associated risk factors have led to the growth in demand for interventional cardiac procedures for both diagnostic and treatment purposes such as angiography and angioplasty. Therefore, the need for vascular closure devices is witnessing an increase as they help in the sealing of the access site in a time-efficient manner.

Moreover, the rising popularity of minimally invasive procedures such as new developments continue to advance the utilization of VCDs. Current trends are focused on developing devices that can safely and efficiently close large-caliber femoral arteriotomies. As trans-catheter aortic valve repair and percutaneous endovascular aneurysm repair become commonplace, there will be tremendous incentive to develop and prove the utility of a simple but effective VCD.

However, complications associated with the vascular closure devices, and limitations of vascular closure devices in closing large bore punctures may prove to be certain restraints to the vascular closures devices market growth.

Vascular Closure Devices Market Segment Analysis:

Vascular Closure Devices Market by Product Type (Active Approximators [Suture-Based, Clip-Based, and Assisted Compression Devices] and Passive Approximators [Sealant-Or-Gel-Based and Bioabsorbable Plugs], and Others), by Access (Femoral And Radial), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the vascular closure devices market, the active approximators category of the vascular devices is expected to amass the significant revenue share in the vascular closure devices market. This can be attributed to their advantageous quality over passive approximators in terms of providing immediate vascular closure compared to passive approximators that take time in ceasing the blood flow. The active approximators are further segmented into suture-based, clip-based, and compression-assist devices.

Furthermore, the passive approximators category is predicted to witness a faster growth in the vascular closure devices in the forecast period due to the growing popularity of the biomaterial-based devices.

North America is expected to dominate in the overall Vascular Closure Devices Market:

Among all the regions, North America is expected to account for the significant market share in the vascular closure devices market. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.

Heart diseases in an umbrella term which encompasses numerous indications such as acute coronary syndrome, atherosclerosis, congestive heart failure among others. As per the information provided by the Centers for Disease Control and Prevention (2023), some of the key risk factors associated with heart diseases are high blood cholesterol, high blood pressure, and smoking. The source further mentioned that about half of Americans (47%) have at least one of these three risk factors.

Furthermore, as per the data provided by the Canadian Institute for Health Information, in 2020, about 2.4 million Canadians suffered from heart disease and was considered to be the second leading cause of death in the country. Therefore, this may result in an increase in the patient population suffering from heart diseases which may in turn increase in the demand for cardiac interventional procedures, thereby boosting the demand for vascular closure devices.

Moreover, the well-established patient care system along with awareness among patients and caregivers regarding the importance of diagnostic and therapeutic interventional procedures is further expected to propel the North American vascular closure devices market growth.

The Asia-Pacific region is expected to witness a significant growth in the vascular closure devices market in the forecast period which can ascribed to the fact that there has been constant efforts in improving healthcare access to the population in the countries in the region and the improvement in disposable income which has further been instrumental in more people opting for healthcare services. All these factors are collectively expected to contribute in the increase in the number of people availing routine diagnostic and treatment services for various diseases such as cardiovascular diseases wherein angiography procedures are majorly used. This is in turn, is expected to drive the demand for vascular closure devices in the region as these devices find application in the sealing of access point entry of the catheter, thereby boosting the growth of the vascular closure devices market in the forecast period.

Vascular Closure Devices Market Key Players:

Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl others.

Recent Developmental Activities in Vascular Closure Devices Market:

In July 2022, Vivasure Medical announced the development of PerQseal® Blue, the new investigational product which is under development. PerQseal Blue is designed specifically for suture less and fully absorbable large-bore venous vessel closure to be used in the percutaneous cardiovascular procedures, such trans-catheter mitral valve repair or replacement (TMVR) and trans-catheter tricuspid valve repair or replacement (TTVR).

In March 2022, CyndRx LLC finalized the pivotal CE Mark trial with the strong clinical outcomes for their vascular closure device AbsorbaSeal(TM) for evaluating the safety and efficacy of this polymer-based device.

In January 2022, Haemonetics Corporation entered into a definitive agreement to acquire Cardiva Medical Inc., a privately owned manufacturer of vascular closure systems.

Key Takeaways from the Vascular Closure Devices Market Report Study

Market size analysis for current vascular closure devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the vascular closure devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global vascular closure devices market.

Various opportunities available for the other competitor in the vascular closure devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030?

Which is the top-performing regions and countries in the current vascular closure devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular closure devices market growth in the coming future?

Target Audience who can be benefited from this Vascular Closure Devices Market Report Study

Vascular Closure Devices products providers

Research organizations and consulting companies

Vascular Closure Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vascular closure devices

Various End-users who want to know more about the vascular closure devices market and latest technological developments in the vascular closure devices market.

Frequently Asked Questions for Vascular Closure Devices Market:

1. What is a Vascular Closure Device?

A vascular closure device are inserted at the end of a procedure with the aim to stop bleeding that occurs at the access point for the procedure in order to promote hemostasis and improve the ambulation time of patients.

2. What is the market for Global Vascular Closure Devices?

Global Vascular Closure Devices Market was valued at USD 1.11 billion in 2023, growing at a CAGR of 6.18% during the forecast period from 2024 to 2030 to reach USD 1.59 billion by 2030.

3. What are the drivers for Global Vascular Closure Devices Market?

Factors such as the growing prevalence of cardiovascular disorders, rising prevalence of risk factors associated with the cardiovascular diseases such as obesity and hypertension, increasing geriatric population, and the surge in the popularity of minimally invasive procedures, are expected to drive the vascular closure devices market.

4. What are the key players operating in Global Vascular Closure Devices Market?

Some of the key market players operating in the vascular closure devices market include Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, Cardival Medical, Inc., Merit Medical Systems, Medtronic, Morris Innovative, TZ Medical, Vasorum Ltd, Tricol Biomedical, Vivasure Medical Ltd, Transluminal Technologies, W. L. Gore & Associates, Inc., Meril Life Sciences Pvt. Ltd, Gem srl, and others.

5. Which region has the highest share in Vascular Closure Devices market?

North America is expected to dominate the overall Vascular Closure Devices market during the forecast period, 2024 to 2030. North America is predicted to account for the dominant market share because of the high prevalence of cardiovascular diseases and associated risk factors, rising population of the elderly, high awareness among people regarding disease management and ability to afford such devices and among other factors in the region.

Table of Contents

1.Vascular Closure Devices Market Report Introduction

2. Vascular Closure Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1. The United States
  • 3.2. Europe
    • 3.2.1. Germany
    • 3.2.2. France
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. U.K.
  • 3.3. Japan

4. Vascular Closure Devices Market Key Factors Analysis

  • 4.1. Vascular Closure Devices Market Drivers
    • 4.1.1. Rising Number of Cardiovascular Diseases
    • 4.1.2. Increase in Prevalence of Risk Factors Associated with CVDs
    • 4.1.3. Growing Popularity of Minimally Invasive Procedures
    • 4.1.4. Surge in Product Innovation Activities
  • 4.2. Vascular Closure Devices Market Restraints and Challenges
    • 4.2.1. Complications Associated with Vascular Closure Devices
    • 4.2.2. Limitations of Vascular Closure Devices in Closing Large Bore Punctures
  • 4.3. Vascular Closure Devices Market Opportunities
    • 4.3.1. Development of Biosorbable Vascular Closure Devices

5. Vascular Closure Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Vascular Closure Devices Market

7. Vascular Closure Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Active Approximators
      • 7.1.1.1. Suture-Based
      • 7.1.1.2. Clip-Based
      • 7.1.1.3. Assisted Compression Devices
    • 7.1.2. Passive Approximators
      • 7.1.2.1. Sealant or Gel-Based
      • 7.1.2.2. Biosorbable Plugs
    • 7.1.3. Others
  • 7.2. By Access Type
    • 7.2.1. Femoral
    • 7.2.2. Radial
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Vascular Closure Devices Market, by Product Type
      • 7.4.1.2. North America Vascular Closure Devices Market, by Access Type
      • 7.4.1.2. North America Vascular Closure Devices Market, by End User
      • 7.4.1.4. North America Vascular Closure Devices Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Vascular Closure Devices Market, by Product Type
      • 7.4.2.2. Europe Vascular Closure Devices Market, by Access Type
      • 7.4.2.3. Europe Vascular Closure Devices Market, by End User
      • 7.4.2.4. Europe Vascular Closure Devices Market, by Country
      • 7.4.2.2.1. France
      • 7.4.2.2.2. Germany
      • 7.4.2.2.3. United Kingdom
      • 7.4.2.2.4. Italy
      • 7.4.2.2.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Vascular Closure Devices Market, by Product Type
      • 7.4.3.2. Asia-Pacific Vascular Closure Devices Market, by Access Type
      • 7.4.3.3. Asia-Pacific Vascular Closure Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Vascular Closure Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Vascular Closure Devices Market, by Product Type
      • 7.4.4.2. RoW Vascular Closure Devices Market, by Access Type
      • 7.4.4.3. RoW Vascular Closure Devices Market, by End User
      • 7.4.4.4. RoW Vascular Closure Devices Market, by Country
      • 7.4.4.3.1. Middle East
      • 7.4.4.3.2. Africa
      • 7.4.4.3.3. South America

8. Vascular Closure Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Vascular Closure Devices Market Company and Product Profiles

  • 9.1. Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Teleflex Incorporated
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Terumo Medical Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Medtronic
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Cardinal Health
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Cardival Medical, Inc
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Merit Medical systems
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Morris Innovative
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. TZ Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Vasorum Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Tricol Biomedical
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Vivasure Medical Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Transluminal Technologies
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. W. L. Gore & Associates, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Meril Life Sciences Pvt. Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Gem srl
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy

10. Project Approach

  • 10.1. Secondary Sources
  • 10.2. Primary Sources
  • 10.3. Data Triangulation
  • 10.4. Key Expert Opinions

11. KOL Views

12. DelveInsight Capabilities

13. Disclaimer

14. About DelveInsight

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Vascular Closure Devices Market
  • Table 3: Vascular Closure Devices Market in Global (2021-2030)
  • Table 4: Vascular Closure Devices Market in Global by Product Type (2021-2030)
  • Table 5: Vascular Closure Devices Market in Global by Access Type (2021-2030)
  • Table 6: Vascular Closure Devices Market in Global by End User (2021-2030)
  • Table 7: Vascular Closure Devices Market in Global by Geography (2021-2030)
  • Table 8: Vascular Closure Devices Market in North America (2021-2030)
  • Table 9: Vascular Closure Devices Market in North America by Product Type (2021-2030)
  • Table 10: Vascular Closure Devices Market in North America by Access Type (2021-2030)
  • Table 11: Vascular Closure Devices Market in North America by End User (2021-2030)
  • Table 12: Vascular Closure Devices Market in North America by Country (2021-2030)
  • Table 13: Vascular Closure Devices Market in the US (2021-2030)
  • Table 14: Vascular Closure Devices Market in Canada (2021-2030)
  • Table 15: Vascular Closure Devices Market in Mexico (2021-2030)
  • Table 16: Vascular Closure Devices Market in Europe (2021-2030)
  • Table 17: Vascular Closure Devices Market in Europe by Product Type (2021-2030)
  • Table 18: Vascular Closure Devices Market in Europe by Access Type (2021-2030)
  • Table 19: Vascular Closure Devices Market in Europe by End User (2021-2030)
  • Table 20: Vascular Closure Devices Market in Europe by Country (2021-2030)
  • Table 21: Vascular Closure Devices Market in France (2021-2030)
  • Table 22: Vascular Closure Devices Market in Germany (2021-2030)
  • Table 23: Vascular Closure Devices Market in the United Kingdom (2021-2030)
  • Table 24: Vascular Closure Devices Market in Italy (2021-2030)
  • Table 25: Vascular Closure Devices Market in Spain (2021-2030)
  • Table 26: Vascular Closure Devices Market in Russia (2021-2030)
  • Table 27: Vascular Closure Devices Market in Rest of Europe (2021-2030)
  • Table 28: Vascular Closure Devices Market in APAC (2021-2030)
  • Table 29: Vascular Closure Devices Market in APAC by Product Type (2021-2030)
  • Table 30: Vascular Closure Devices Market in APAC by Access Type (2021-2030)
  • Table 31: Vascular Closure Devices Market in APAC by End User (2021-2030)
  • Table 32: Vascular Closure Devices Market in APAC by Country (2021-2030)
  • Table 33: Vascular Closure Devices Market in China (2021-2030)
  • Table 34: Vascular Closure Devices Market in Japan (2021-2030)
  • Table 35: Vascular Closure Devices Market in India (2021-2030)
  • Table 36: Vascular Closure Devices Market in Australia (2021-2030)
  • Table 37: Vascular Closure Devices Market in South Korea (2021-2030)
  • Table 38: Vascular Closure Devices Market in Rest of APAC (2021-2030)
  • Table 39: Vascular Closure Devices Market in Rest of World (2021-2030)
  • Table 40: Vascular Closure Devices Market in RoW by Product Type (2021-2030)
  • Table 41: Vascular Closure Devices Market in RoW by Access Type (2021-2030)
  • Table 42: Vascular Closure Devices Market in RoW by End User (2021-2030)
  • Table 43: Vascular Closure Devices Market in RoW by Region (2021-2030)
  • Table 44: Vascular Closure Devices Market in Middle East (2021-2030)
  • Table 45: Vascular Closure Devices Market in Africa (2021-2030)
  • Table 46: Vascular Closure Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Vascular Closure Devices Market

Figures 3: Vascular Closure Devices Market in Global (2021-2030)

Figures 4: Vascular Closure Devices Market in Global by Product Type (2021-2030)

Figures 5: Vascular Closure Devices Market in Global by Access Type (2021-2030)

Figures 6: Vascular Closure Devices Market in Global by End User (2021-2030)

Figures 7: Vascular Closure Devices Market in Global by Geography (2021-2030)

Figures 8: Vascular Closure Devices Market in North America (2021-2030)

Figures 9: Vascular Closure Devices Market in North America by Product Type (2021-2030)

Figures 10: Vascular Closure Devices Market in North America by Access Type (2021-2030)

Figures 11: Vascular Closure Devices Market in North America by End User (2021-2030)

Figures 12: Vascular Closure Devices Market in North America by Country (2021-2030)

Figures 13: Vascular Closure Devices Market in the US (2021-2030)

Figures 14: Vascular Closure Devices Market in Canada (2021-2030)

Figures 15: Vascular Closure Devices Market in Mexico (2021-2030)

Figures 16: Vascular Closure Devices Market in Europe (2021-2030)

Figures 17: Vascular Closure Devices Market in Europe by Product Type (2021-2030)

Figures 18: Vascular Closure Devices Market in Europe by Access Type (2021-2030)

Figures 19: Vascular Closure Devices Market in Europe by End User (2021-2030)

Figures 20: Vascular Closure Devices Market in Europe by Country (2021-2030)

Figures 21: Vascular Closure Devices Market in France (2021-2030)

Figures 22: Vascular Closure Devices Market in Germany (2021-2030)

Figures 23: Vascular Closure Devices Market in the United Kingdom (2021-2030)

Figures 24: Vascular Closure Devices Market in Italy (2021-2030)

Figures 25: Vascular Closure Devices Market in Spain (2021-2030)

Figures 26: Vascular Closure Devices Market in Russia (2021-2030)

Figures 27: Vascular Closure Devices Market in Rest of Europe (2021-2030)

Figures 28: Vascular Closure Devices Market in APAC (2021-2030)

Figures 29: Vascular Closure Devices Market in APAC by Product Type (2021-2030)

Figures 30: Vascular Closure Devices Market in APAC by Access Type (2021-2030)

Figures 31: Vascular Closure Devices Market in APAC by End User (2021-2030)

Figures 32: Vascular Closure Devices Market in APAC by Country (2021-2030)

Figures 33: Vascular Closure Devices Market in China (2021-2030)

Figures 34: Vascular Closure Devices Market in Japan (2021-2030)

Figures 35: Vascular Closure Devices Market in India (2021-2030)

Figures 36: Vascular Closure Devices Market in Australia (2021-2030)

Figures 37: Vascular Closure Devices Market in South Korea (2021-2030)

Figures 38: Vascular Closure Devices Market in Rest of APAC (2021-2030)

Figures 39: Vascular Closure Devices Market in Rest of World (2021-2030)

Figures 40: Vascular Closure Devices Market in RoW by Product Type (2021-2030)

Figures 41: Vascular Closure Devices Market in RoW by Access Type (2021-2030)

Figures 42: Vascular Closure Devices Market in RoW by End User (2021-2030)

Figures 43: Vascular Closure Devices Market in RoW by Region (2021-2030)

Figures 44: Vascular Closure Devices Market in Middle East (2021-2030)

Figures 45: Vascular Closure Devices Market in Africa (2021-2030)

Figures 46: Vascular Closure Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis